Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.13 trillion and total revenue of $110.17 billion.
Market Cap
1.13T
Revenue
110.17B
Profits
-39.7B
PE Ratio
n/a
Profit Margin
-36.03%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.04B | 1.99% | 641,431 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.01B | 1.27% | 327,586 | 14.34B |
| 3 | ARGX | argenx SE | 48.76B | 2.29% | 234,158 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.16B | 1.86% | 613,270 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 34.68B | 2.93% | 177,357 | 5.34B |
| 6 | INSM | Insmed Incorporated | 34.48B | -2.02% | 1,920,327 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 27.55B | 1.90% | 1,485,828 | 2.38B |
| 8 | BNTX | BioNTech SE | 23.23B | 2.50% | 327,979 | 3.37B |
| 9 | MRNA | Moderna, Inc. | 20.57B | 3.53% | 3,264,945 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.25B | 1.98% | 1,811,288 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 19.13B | 0.24% | 652,907 | - |
| 12 | INCY | Incyte Corporation | 18.96B | 1.69% | 497,136 | 5.14B |
| 13 | GMAB | Genmab A/S | 17.17B | 2.17% | 1,467,487 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 14.58B | -2.13% | 1,347,879 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.35B | 2.88% | 871,804 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 14.19B | 4.88% | 579,605 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.42B | 1.76% | 799,528 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.04B | 2.47% | 651,366 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.84B | 0.80% | 266,962 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.53B | 0.95% | 1,348,725 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.02B | 1.96% | 718,819 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.35B | 1.75% | 380,040 | 5.37M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.99B | 4.99% | 1,024,973 | 1.09B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 8.85B | 2.54% | 325,984 | 638.50M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 8.79B | 2.88% | 192,891 | 7.46M |
| 26 | PCVX | Vaxcyte, Inc. | 8.77B | 0.46% | 761,055 | - |
| 27 | TECH | Bio-Techne Corporation | 8.58B | 1.91% | 1,362,377 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.17B | 1.66% | 228,478 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.12B | 0.67% | 1,037,214 | 88.04M |
| 30 | KRYS | Krystal Biotech, Inc. | 7.76B | -0.17% | 219,008 | 389.13M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.74B | 2.68% | 914,597 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 7.06B | -0.29% | 12,134,808 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.02B | 1.02% | 211,684 | 39.21M |
| 34 | BLTE | Belite Bio, Inc | 6.99B | 4.72% | 133,441 | - |
| 35 | ACLX | Arcellx, Inc. | 6.73B | -0.01% | 412,220 | 22.29M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.54B | -1.23% | 296,942 | 46.02M |
| 37 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.25% | 2,464,072 | 15.00M |
| 38 | APGE | Apogee Therapeutics, Inc. | 6.10B | -0.84% | 541,599 | - |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | 0.07% | 11,949,124 | - |
| 40 | MIRM | Mirum Pharmaceuticals, Inc. | 5.90B | 2.21% | 330,005 | 521.31M |
| 41 | COGT | Cogent Biosciences, Inc. | 5.89B | 2.72% | 1,201,710 | - |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.88B | 2.16% | 501,508 | 1.73B |
| 43 | CGON | CG Oncology, Inc. | 5.83B | -1.03% | 766,388 | 4.04M |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.81B | -1.86% | 543,317 | 189.76M |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.73B | -0.12% | 882,319 | - |
| 46 | CELC | Celcuity Inc. | 5.62B | 0.69% | 303,994 | - |
| 47 | CAI | Caris Life Sciences, Inc. | 5.48B | 3.52% | 861,125 | 812.03M |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.44B | -1.13% | 384,923 | 7.50M |
| 49 | ERAS | Erasca, Inc. | 5.24B | -1.23% | 2,570,972 | - |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | 0.01% | 3,101,495 | 1.00B |
| 51 | IMVT | Immunovant, Inc. | 5.05B | 0.77% | 846,588 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 4.99B | 1.20% | 940,075 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.87B | 2.15% | 1,251,052 | 3.51M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.64B | 1.64% | 490,089 | 2.04M |
| 55 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.03% | 1,893,607 | 634.21M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.46B | 0.48% | 762,283 | 761.41M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.16B | 1.75% | 158,306 | 268.09M |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.16B | 3.44% | 830,873 | 7.70M |
| 59 | SYRE | Spyre Therapeutics, Inc. | 4.03B | 0.27% | 565,425 | - |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.91B | 0.18% | 463,940 | 22.50M |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.89B | -0.42% | 1,260,467 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.83B | 1.58% | 816,287 | 1.07B |
| 63 | GPCR | Structure Therapeutics Inc. | 3.78B | -2.43% | 601,520 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.55B | 1.69% | 357,782 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.35B | 0.67% | 1,822,408 | 1.03B |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.28B | 1.14% | 69,600 | 803.79M |
| 67 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.10B | 1.64% | 804,762 | 588.99M |
| 68 | DNLI | Denali Therapeutics Inc. | 3.08B | 0.05% | 512,560 | - |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.04B | 4.03% | 297,202 | 451.36M |
| 70 | ARQT | Arcutis Biotherapeutics, Inc. | 3.04B | 5.46% | 706,583 | 376.07M |
| 71 | ORKA | Oruka Therapeutics, Inc. | 3.04B | 1.20% | 1,119,297 | - |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.01B | 0.50% | 650,668 | - |
| 73 | ALMS | Alumis Inc. | 2.94B | 3.50% | 801,266 | 24.05M |
| 74 | TVTX | Travere Therapeutics, Inc. | 2.93B | 0.06% | 732,822 | 490.73M |
| 75 | VERA | Vera Therapeutics, Inc. | 2.89B | 1.15% | 581,913 | - |
| 76 | TNGX | Tango Therapeutics, Inc. | 2.85B | 1.01% | 1,126,880 | 62.38M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.84B | 2.81% | 427,714 | 247.00M |
| 78 | SLNO | Soleno Therapeutics, Inc. | 2.71B | 0.27% | 11,734,507 | 190.41M |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.70B | -0.49% | 987,538 | 218.71M |
| 80 | RLAY | Relay Therapeutics, Inc. | 2.58B | 7.20% | 2,781,432 | 15.36M |
| 81 | KOD | Kodiak Sciences Inc. | 2.55B | -1.02% | 669,486 | - |
| 82 | ELVN | Enliven Therapeutics, Inc. | 2.54B | -1.53% | 898,063 | - |
| 83 | IRON | Disc Medicine, Inc. | 2.52B | -1.38% | 101,367 | - |
| 84 | BEAM | Beam Therapeutics Inc. | 2.48B | 1.88% | 1,200,965 | 139.74M |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.47B | 0.57% | 893,589 | 1.55M |
| 86 | IMNM | Immunome, Inc. | 2.45B | 0.39% | 527,928 | 6.94M |
| 87 | ZLAB | Zai Lab Limited | 2.41B | 1.81% | 791,872 | 460.16M |
| 88 | AAPG | Ascentage Pharma Group International | 2.40B | -4.87% | 851 | 82.08M |
| 89 | SRPT | Sarepta Therapeutics, Inc. | 2.35B | -3.08% | 1,497,871 | 2.20B |
| 90 | ADMA | ADMA Biologics, Inc. | 2.33B | 5.62% | 2,594,932 | 510.17M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.28B | -2.40% | 537,933 | - |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.27B | -0.04% | 1,068,658 | 673.00M |
| 93 | ADPT | Adaptive Biotechnologies Corporation | 2.26B | 7.15% | 1,327,438 | 276.98M |
| 94 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | -0.12% | 955,020 | 158.18M |
| 95 | SNDX | Syndax Pharmaceuticals, Inc. | 2.15B | -1.22% | 663,217 | 172.35M |
| 96 | MANE | Veradermics, Incorporated | 2.13B | 0.71% | 341,295 | - |
| 97 | NKTR | Nektar Therapeutics | 2.13B | -2.52% | 541,846 | 55.23M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | 0.19% | 492,876 | 283.06M |
| 99 | DFTX | Definium Therapeutics, Inc. | 2.09B | 1.75% | 887,537 | - |
| 100 | STOK | Stoke Therapeutics, Inc. | 2.07B | 3.40% | 665,944 | 184.42M |
| 101 | TYRA | Tyra Biosciences, Inc. | 2.01B | -0.87% | 521,086 | - |
| 102 | AGIO | Agios Pharmaceuticals, Inc. | 1.99B | -3.19% | 662,183 | 54.03M |
| 103 | ZYME | Zymeworks Inc. | 1.97B | 2.77% | 350,825 | 105.97M |
| 104 | GLPG | Galapagos NV | 1.88B | -0.80% | 73,180 | 1.31B |
| 105 | ANAB | AnaptysBio, Inc. | 1.86B | 4.37% | 225,741 | 234.60M |
| 106 | OCUL | Ocular Therapeutix, Inc. | 1.81B | -0.24% | 2,533,797 | 51.95M |
| 107 | MESO | Mesoblast Limited | 1.81B | 1.06% | 261,645 | 65.38M |
| 108 | CAPR | Capricor Therapeutics, Inc. | 1.81B | -1.78% | 392,334 | 11.13M |
| 109 | PHVS | Pharvaris N.V. | 1.80B | -0.93% | 134,024 | - |
| 110 | RXRX | Recursion Pharmaceuticals, Inc. | 1.77B | 5.33% | 13,502,581 | 74.68M |
| 111 | PVLA | Palvella Therapeutics, Inc. | 1.76B | 2.25% | 159,821 | - |
| 112 | INVA | Innoviva, Inc. | 1.74B | 0.86% | 327,354 | 411.33M |
| 113 | VCEL | Vericel Corporation | 1.72B | 1.35% | 244,973 | 276.26M |
| 114 | TRVI | Trevi Therapeutics, Inc. | 1.68B | -0.08% | 697,005 | - |
| 115 | SION | Sionna Therapeutics, Inc. | 1.65B | -0.20% | 150,696 | - |
| 116 | HRMY | Harmony Biosciences Holdings, Inc. | 1.64B | 2.79% | 522,730 | 868.45M |
| 117 | NRIX | Nurix Therapeutics, Inc. | 1.64B | -3.18% | 1,059,484 | 71.78M |
| 118 | NTLA | Intellia Therapeutics, Inc. | 1.62B | 0.96% | 1,996,428 | 67.67M |
| 119 | IMCR | Immunocore Holdings plc | 1.62B | -0.28% | 333,072 | 400.02M |
| 120 | OCS | Oculis Holding AG | 1.61B | 2.88% | 97,858 | 1.51M |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.60B | -0.15% | 79,251 | - |
| 122 | NUVB | Nuvation Bio Inc. | 1.55B | 0.22% | 1,424,765 | 62.90M |
| 123 | DMRA | Damora Therapeutics, Inc. | 1.54B | 4.92% | 97,933 | - |
| 124 | VIR | Vir Biotechnology, Inc. | 1.54B | 5.23% | 1,606,014 | 68.56M |
| 125 | GENB | Generate Biomedicines, Inc. | 1.52B | 1.06% | 263,702 | 31.89M |
| 126 | ARDX | Ardelyx, Inc. | 1.50B | 2.77% | 1,750,370 | 407.32M |
| 127 | MBX | MBX Biosciences, Inc. | 1.50B | 4.54% | 298,460 | - |
| 128 | SVRA | Savara Inc. | 1.49B | 1.99% | 693,451 | - |
| 129 | VRDN | Viridian Therapeutics, Inc. | 1.46B | 2.36% | 2,798,417 | 70.85M |
| 130 | NBTX | Nanobiotix S.A. | 1.44B | 1.79% | 88,857 | 38.27M |
| 131 | PGEN | Precigen, Inc. | 1.43B | -1.70% | 1,981,612 | 9.68M |
| 132 | BCAX | Bicara Therapeutics Inc. | 1.42B | 1.69% | 224,900 | - |
| 133 | IMTX | Immatics N.V. | 1.41B | 2.34% | 287,424 | 56.67M |
| 134 | BHVN | Biohaven Ltd. | 1.40B | 0.76% | 749,015 | - |
| 135 | MAZE | Maze Therapeutics, Inc. | 1.40B | -0.56% | 588,405 | 2.50M |
| 136 | IOVA | Iovance Biotherapeutics, Inc. | 1.38B | 1.05% | 8,954,701 | 263.50M |
| 137 | ATAI | AtaiBeckley Inc. | 1.37B | -0.66% | 3,030,044 | 4.09M |
| 138 | OLMA | Olema Pharmaceuticals, Inc. | 1.37B | 2.82% | 524,761 | - |
| 139 | GLUE | Monte Rosa Therapeutics, Inc. | 1.36B | -0.53% | 336,570 | 123.67M |
| 140 | NVAX | Novavax, Inc. | 1.35B | 3.63% | 2,104,768 | 1.12B |
| 141 | WVE | Wave Life Sciences Ltd. | 1.33B | -0.42% | 1,438,639 | 42.73M |
| 142 | MLTX | MoonLake Immunotherapeutics | 1.33B | 8.49% | 1,197,652 | - |
| 143 | TSHA | Taysha Gene Therapies, Inc. | 1.31B | -0.11% | 860,720 | 9.77M |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | 3.00% | 394,298 | - |
| 145 | ZBIO | Zenas BioPharma, Inc. | 1.22B | -8.87% | 460,509 | 10.00M |
| 146 | EYPT | EyePoint, Inc. | 1.17B | 3.32% | 662,915 | 31.37M |
| 147 | PHAR | Pharming Group N.V. | 1.15B | 1.58% | 24,305 | 376.13M |
| 148 | DBVT | DBV Technologies S.A. | 1.14B | 4.35% | 85,664 | 5.64M |
| 149 | AVBP | ArriVent BioPharma, Inc. | 1.13B | 1.07% | 262,681 | - |
| 150 | GERN | Geron Corporation | 1.10B | -1.15% | 14,129,840 | 183.88M |
| 151 | SEPN | Septerna, Inc. | 1.10B | -1.65% | 105,512 | 45.95M |
| 152 | MPLT | MapLight Therapeutics, Inc. | 1.06B | -0.08% | 282,775 | - |
| 153 | ABCL | AbCellera Biologics Inc. | 1.04B | 3.64% | 2,113,411 | 75.13M |
| 154 | XERS | Xeris Biopharma Holdings, Inc. | 1.02B | 0.94% | 1,172,441 | 291.85M |
| 155 | IVA | Inventiva S.A. | 1.02B | -0.37% | 170,180 | 9.31M |
| 156 | QURE | uniQure N.V. | 999.22M | -6.77% | 865,909 | 16.10M |
| 157 | KALV | KalVista Pharmaceuticals, Inc. | 985.52M | -4.37% | 569,054 | 73.62M |
| 158 | ANNX | Annexon, Inc. | 982.10M | 2.17% | 1,358,931 | - |
| 159 | INBX | Inhibrx Biosciences, Inc. | 976.19M | 7.19% | 123,013 | 1.30M |
| 160 | CMPX | Compass Therapeutics, Inc. | 968.87M | 1.32% | 1,574,426 | 850.00K |
| 161 | EVMN | Evommune, Inc. | 963.13M | 7.87% | 275,108 | 13.00M |
| 162 | URGN | UroGen Pharma Ltd. | 930.81M | 6.05% | 731,422 | 109.79M |
| 163 | GHRS | GH Research PLC | 929.20M | 2.04% | 33,395 | - |
| 164 | PHAT | Phathom Pharmaceuticals, Inc. | 926.67M | 1.82% | 580,766 | 175.11M |
| 165 | CTMX | CytomX Therapeutics, Inc. | 926.32M | -0.35% | 4,174,523 | 76.20M |
| 166 | AKTS | Aktis Oncology, Inc. | 925.87M | 0.18% | 129,373 | 6.50M |
| 167 | CGEM | Cullinan Therapeutics, Inc. | 903.35M | 0.44% | 414,099 | - |
| 168 | ORIC | ORIC Pharmaceuticals, Inc. | 903.22M | 1.47% | 1,172,034 | - |
| 169 | FTRE | Fortrea Holdings Inc. | 891.99M | 0.32% | 661,447 | 2.72B |
| 170 | XNCR | Xencor, Inc. | 891.80M | -1.22% | 629,884 | 125.58M |
| 171 | JANX | Janux Therapeutics, Inc. | 882.67M | -2.81% | 430,436 | 10.00M |
| 172 | SLS | SELLAS Life Sciences Group, Inc. | 858.40M | 5.99% | 3,274,959 | - |
| 173 | ABUS | Arbutus Biopharma Corporation | 856.19M | -1.79% | 1,545,196 | 14.08M |
| 174 | VOR | Vor Biopharma Inc. | 856.13M | -6.23% | 1,469,307 | - |
| 175 | SANA | Sana Biotechnology, Inc. | 853.97M | 1.59% | 1,442,381 | - |
| 176 | TBPH | Theravance Biopharma, Inc. | 851.18M | -0.18% | 184,224 | 107.46M |
| 177 | JBIO | Jade Biosciences, Inc. | 826.05M | 2.38% | 406,875 | - |
| 178 | OMER | Omeros Corporation | 817.16M | 3.37% | 741,958 | - |
| 179 | SPRY | ARS Pharmaceuticals, Inc. | 807.29M | -0.25% | 721,388 | 84.28M |
| 180 | MRVI | Maravai LifeSciences Holdings, Inc. | 796.91M | 7.27% | 1,421,299 | 185.74M |
| 181 | MNKD | MannKind Corporation | 791.82M | - | 1,714,828 | 348.97M |
| 182 | SLDB | Solid Biosciences Inc. | 782.21M | 2.71% | 409,647 | - |
| 183 | KURA | Kura Oncology, Inc. | 773.77M | -0.68% | 646,948 | 67.48M |
| 184 | DSGN | Design Therapeutics, Inc. | 772.14M | 2.45% | 219,901 | - |
| 185 | MGTX | MeiraGTx Holdings plc | 761.52M | -1.68% | 441,074 | 81.39M |
| 186 | TENX | Tenax Therapeutics, Inc. | 753.50M | 2.67% | 305,245 | - |
| 187 | DRUG | Bright Minds Biosciences Inc. | 750.27M | 6.47% | 223,934 | - |
| 188 | RLMD | Relmada Therapeutics, Inc. | 724.78M | 2.37% | 442,565 | - |
| 189 | SGP | SpyGlass Pharma, Inc. | 716.83M | 1.78% | 103,760 | - |
| 190 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.78M | 5.00% | 1,828,284 | 49.80M |
| 191 | ARVN | Arvinas, Inc. | 710.61M | -2.29% | 458,677 | 262.60M |
| 192 | ANRO | Alto Neuroscience, Inc. | 703.12M | 3.09% | 181,307 | - |
| 193 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 690.68M | 2.74% | 281,971 | - |
| 194 | LBRX | LB Pharmaceuticals Inc | 651.20M | 1.74% | 125,553 | - |
| 195 | GYRE | Gyre Therapeutics, Inc. | 646.50M | -0.56% | 60,086 | 116.59M |
| 196 | ALLO | Allogene Therapeutics, Inc. | 641.14M | 0.38% | 2,710,195 | 22.00K |
| 197 | DRTS | Alpha Tau Medical Ltd. | 631.91M | 0.56% | 324,887 | - |
| 198 | OCGN | Ocugen, Inc. | 626.80M | 6.61% | 3,579,264 | 4.41M |
| 199 | PRME | Prime Medicine, Inc. | 614.47M | 1.76% | 1,155,834 | 4.63M |
| 200 | CBIO | Crescent Biopharma, Inc. | 603.66M | -5.39% | 86,289 | 10.84M |
| 201 | MDXG | MiMedx Group, Inc. | 588.32M | 2.59% | 501,509 | 418.63M |
| 202 | PRTA | Prothena Corporation plc | 572.78M | 2.70% | 288,156 | 9.68M |
| 203 | CRMD | CorMedix Inc. | 569.95M | 0.56% | 631,081 | 311.71M |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 564.81M | -0.62% | 377,442 | 106.47M |
| 205 | TECX | Tectonic Therapeutic, Inc. | 561.05M | 2.89% | 101,659 | - |
| 206 | PROK | ProKidney Corp. | 555.53M | 0.55% | 564,952 | 893.00K |
| 207 | VALN | Valneva SE | 546.53M | 5.38% | 37,018 | 205.07M |
| 208 | KYTX | Kyverna Therapeutics, Inc. | 546.51M | -3.11% | 710,481 | - |
| 209 | RIGL | Rigel Pharmaceuticals, Inc. | 544.96M | 2.68% | 247,841 | 294.28M |
| 210 | ZURA | Zura Bio Limited | 540.82M | 0.88% | 525,138 | - |
| 211 | ACRS | Aclaris Therapeutics, Inc. | 537.91M | 3.20% | 564,721 | 7.83M |
| 212 | LYEL | Lyell Immunopharma, Inc. | 532.59M | 4.82% | 44,701 | 36.00K |
| 213 | UPB | Upstream Bio, Inc. | 528.96M | 0.21% | 289,525 | 2.85M |
| 214 | LRMR | Larimar Therapeutics, Inc. | 526.69M | 0.60% | 951,068 | - |
| 215 | FULC | Fulcrum Therapeutics, Inc. | 525.14M | 0.70% | 393,370 | 80.00M |
| 216 | REPL | Replimune Group, Inc. | 514.43M | -20.13% | 4,463,927 | - |
| 217 | FDMT | 4D Molecular Therapeutics, Inc. | 511.54M | -2.15% | 477,250 | 85.21M |
| 218 | TRDA | Entrada Therapeutics, Inc. | 509.04M | 2.09% | 96,889 | 25.42M |
| 219 | STTK | Shattuck Labs, Inc. | 497.37M | 2.51% | 313,989 | 1.00M |
| 220 | EIKN | Eikon Therapeutics, Inc. | 495.37M | 4.21% | 305,872 | - |
| 221 | ENGN | enGene Holdings Inc. | 494.38M | 0.68% | 84,048 | - |
| 222 | AGMB | AgomAb Therapeutics NV | 487.12M | -4.90% | 116,743 | - |
| 223 | CTNM | Contineum Therapeutics, Inc. | 482.38M | 1.49% | 92,346 | - |
| 224 | VSTM | Verastem, Inc. | 476.94M | -0.37% | 813,971 | 30.91M |
| 225 | FBRX | Forte Biosciences, Inc. | 476.71M | -2.94% | 62,195 | - |
| 226 | VTVT | vTv Therapeutics Inc. | 476.53M | 0.39% | 68,296 | 17.00K |
| 227 | AVIR | Atea Pharmaceuticals, Inc. | 474.45M | -0.25% | 262,303 | - |
| 228 | LXEO | Lexeo Therapeutics, Inc. | 473.42M | 1.27% | 667,845 | - |
| 229 | ADCT | ADC Therapeutics SA | 471.97M | -0.13% | 223,319 | 81.36M |
| 230 | ASMB | Assembly Biosciences, Inc. | 463.03M | 2.31% | 87,089 | 72.30M |
| 231 | ABSI | Absci Corporation | 455.24M | 1.88% | 2,424,109 | 2.80M |
| 232 | IMMX | Immix Biopharma, Inc. | 453.25M | -5.94% | 408,963 | - |
| 233 | STRO | Sutro Biopharma, Inc. | 450.30M | 5.72% | 166,996 | 102.48M |
| 234 | RGNX | REGENXBIO Inc. | 445.97M | -1.82% | 370,106 | 170.44M |
| 235 | ANL | Adlai Nortye Ltd. | 443.17M | 22.55% | 1,155,156 | -1.35M |
| 236 | ARMP | Armata Pharmaceuticals, Inc. | 442.89M | 1.17% | 77,156 | 4.90M |
| 237 | ALT | Altimmune, Inc. | 437.80M | -0.44% | 1,293,494 | 41.00K |
| 238 | VNDA | Vanda Pharmaceuticals Inc. | 434.44M | -1.34% | 871,345 | 216.11M |
| 239 | AURA | Aura Biosciences, Inc. | 433.02M | 1.81% | 227,949 | - |
| 240 | EPRX | Eupraxia Pharmaceuticals Inc. | 416.76M | 1.92% | 120,183 | - |
| 241 | IPSC | Century Therapeutics, Inc. | 408.87M | 0.66% | 730,818 | 109.16M |
| 242 | YDES | YD Bio Limited | 408.56M | -16.76% | 17,602 | 510.36K |
| 243 | XOMA | XOMA Royalty Corporation | 407.64M | -1.07% | 125,801 | 52.15M |
| 244 | NAUT | Nautilus Biotechnology, Inc. | 404.37M | 2.40% | 247,749 | - |
| 245 | DNA | Ginkgo Bioworks Holdings, Inc. | 397.56M | 0.15% | 549,654 | 170.16M |
| 246 | NMRA | Neumora Therapeutics, Inc. | 395.94M | 2.11% | 821,658 | - |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 395.53M | 1.49% | 39,505 | 66.98M |
| 248 | AUTL | Autolus Therapeutics plc | 392.56M | 8.46% | 1,527,556 | 75.39M |
| 249 | RCKT | Rocket Pharmaceuticals, Inc. | 387.93M | 2.16% | 1,599,781 | - |
| 250 | LCTX | Lineage Cell Therapeutics, Inc. | 383.59M | 1.32% | 755,337 | 14.56M |
| 251 | MNPR | Monopar Therapeutics Inc. | 380.52M | 6.06% | 76,543 | - |
| 252 | PBYI | Puma Biotechnology, Inc. | 376.49M | 6.17% | 344,611 | 228.37M |
| 253 | BNTC | Benitec Biopharma Inc. | 375.09M | 0.37% | 56,146 | - |
| 254 | IVVD | Invivyd, Inc. | 374.72M | 2.71% | 1,286,239 | 53.43M |
| 255 | RZLT | Rezolute, Inc. | 367.71M | 7.27% | 1,483,875 | - |
| 256 | XFOR | X4 Pharmaceuticals, Inc. | 366.86M | 8.18% | 922,878 | 35.11M |
| 257 | PRTC | PureTech Health plc | 366.39M | 1.06% | 2,724 | 6.39M |
| 258 | NAGE | Niagen Bioscience, Inc. | 365.93M | 2.01% | 319,623 | 129.42M |
| 259 | CADL | Candel Therapeutics, Inc. | 359.64M | -0.81% | 680,950 | - |
| 260 | IRD | Opus Genetics, Inc. | 359.30M | 2.64% | 603,365 | 14.20M |
| 261 | PRLD | Prelude Therapeutics Incorporated | 354.07M | -2.50% | 335,676 | 12.14M |
| 262 | IMRX | Immuneering Corporation | 353.00M | 4.40% | 394,499 | - |
| 263 | BCYC | Bicycle Therapeutics plc | 346.79M | 1.53% | 160,928 | 72.59M |
| 264 | NGEN | NervGen Pharma Corp. | 346.79M | 7.93% | 330,558 | - |
| 265 | OVID | Ovid Therapeutics Inc. | 346.17M | 2.54% | 3,282,575 | 7.25M |
| 266 | CABA | Cabaletta Bio, Inc. | 340.65M | -0.33% | 1,125,215 | - |
| 267 | CLYM | Climb Bio, Inc. | 337.72M | 2.91% | 278,209 | - |
| 268 | NGNE | Neurogene Inc. | 331.58M | 1.82% | 55,364 | 925.00K |
| 269 | AVTX | Avalo Therapeutics, Inc. | 328.15M | -9.55% | 1,213,216 | 59.00K |
| 270 | GLSI | Greenwich LifeSciences, Inc. | 327.11M | 4.89% | 156,470 | - |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 327.07M | -7.33% | 127,726 | - |
| 272 | ACIU | AC Immune SA | 316.45M | 2.57% | 450,894 | 4.51M |
| 273 | PALI | Palisade Bio, Inc. | 314.75M | -1.57% | 1,322,822 | - |
| 274 | SRZN | Surrozen, Inc. | 295.50M | -0.17% | 40,391 | 3.48M |
| 275 | LENZ | LENZ Therapeutics, Inc. | 295.36M | -2.99% | 331,582 | 19.09M |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 294.83M | -1.70% | 518,432 | 1.00 |
| 277 | FHTX | Foghorn Therapeutics Inc. | 285.87M | -2.01% | 94,138 | 30.91M |
| 278 | NBP | NovaBridge Biosciences | 282.46M | -1.21% | 1,719,659 | - |
| 279 | TARA | Protara Therapeutics, Inc. | 281.51M | 1.26% | 349,817 | - |
| 280 | AVXL | Anavex Life Sciences Corp. | 280.80M | -1.62% | 680,003 | - |
| 281 | CCCC | C4 Therapeutics, Inc. | 280.54M | 4.93% | 1,334,196 | 35.95M |
| 282 | ABEO | Abeona Therapeutics Inc. | 276.97M | 0.94% | 449,182 | 5.82M |
| 283 | SLN | Silence Therapeutics plc | 273.48M | 3.39% | 240,238 | 559.00K |
| 284 | PLYX | Polaryx Therapeutics, Inc. | 271.28M | 11.05% | 128,483 | - |
| 285 | EDIT | Editas Medicine, Inc. | 266.21M | -0.73% | 806,326 | 40.52M |
| 286 | ALEC | Alector, Inc. | 265.97M | -2.43% | 211,538 | 21.05M |
| 287 | ADAG | Adagene Inc. | 262.31M | -10.38% | 817,296 | 7.67M |
| 288 | HELP | Cybin Inc. | 261.69M | -0.38% | 347,116 | - |
| 289 | SABS | SAB Biotherapeutics, Inc. | 261.43M | -1.06% | 148,921 | 114.70K |
| 290 | OBIO | Orchestra BioMed Holdings, Inc. | 256.03M | 2.70% | 56,840 | 33.48M |
| 291 | CHRS | Coherus Oncology, Inc. | 252.56M | 0.90% | 600,345 | 42.17M |
| 292 | ALXO | ALX Oncology Holdings Inc. | 249.40M | 3.55% | 324,802 | - |
| 293 | KROS | Keros Therapeutics, Inc. | 245.98M | 1.92% | 235,128 | 244.06M |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 244.52M | 5.19% | 133,138 | 19.39M |
| 295 | CLLS | Cellectis S.A. | 242.59M | 7.14% | 8,753 | 79.59M |
| 296 | CAMP | Camp4 Therapeutics Corporation | 240.91M | -0.22% | 24,326 | 3.50M |
| 297 | ARCT | Arcturus Therapeutics Holdings Inc. | 240.17M | -0.71% | 498,806 | 82.03M |
| 298 | CNTX | Context Therapeutics Inc. | 239.80M | -0.38% | 336,506 | - |
| 299 | ELDN | Eledon Pharmaceuticals, Inc. | 233.22M | 0.66% | 954,963 | - |
| 300 | VYGR | Voyager Therapeutics, Inc. | 232.14M | -1.64% | 341,698 | 40.37M |
| 301 | NERV | Minerva Neurosciences, Inc. | 231.95M | 3.47% | 200,690 | - |
| 302 | ENLV | Enlivex Ltd. | 227.20M | 14.84% | 1,369,136 | - |
| 303 | FENC | Fennec Pharmaceuticals Inc. | 224.43M | 3.01% | 121,827 | 44.64M |
| 304 | OABI | OmniAb, Inc. | 222.24M | 1.66% | 239,110 | 18.67M |
| 305 | MDWD | MediWound Ltd. | 221.44M | 1.53% | 87,457 | 16.96M |
| 306 | MIST | Milestone Pharmaceuticals Inc. | 217.09M | 9.94% | 3,095,593 | 1.55M |
| 307 | NVCT | Nuvectis Pharma, Inc. | 216.17M | 2.90% | 38,933 | - |
| 308 | CGEN | Compugen Ltd. | 216.06M | -1.51% | 254,507 | 72.76M |
| 309 | MGNX | MacroGenics, Inc. | 214.82M | 0.90% | 828,538 | 149.50M |
| 310 | MENS | Jyong Biotech Ltd. | 204.55M | 5.14% | 112,294 | - |
| 311 | ZNTL | Zentalis Pharmaceuticals, Inc. | 199.67M | 5.43% | 339,348 | 26.87M |
| 312 | CDXS | Codexis, Inc. | 197.19M | 9.60% | 1,465,361 | 70.39M |
| 313 | KRRO | Korro Bio, Inc. | 194.27M | -3.16% | 104,186 | 6.39M |
| 314 | CRBU | Caribou Biosciences, Inc. | 188.44M | 4.84% | 908,270 | 11.16M |
| 315 | ELTX | Elicio Therapeutics, Inc. | 185.25M | -0.20% | 160,256 | - |
| 316 | ABOS | Acumen Pharmaceuticals, Inc. | 185.23M | -2.47% | 305,086 | - |
| 317 | PRQR | ProQR Therapeutics N.V. | 183.33M | 2.35% | 642,924 | 19.19M |
| 318 | TNXP | Tonix Pharmaceuticals Holding Corp. | 183.11M | -1.38% | 476,981 | 13.11M |
| 319 | CNTN | Canton Strategic Holdings, Inc. | 183.00M | 3.19% | 301,456 | - |
| 320 | SGMT | Sagimet Biosciences Inc. | 180.52M | 9.06% | 429,625 | - |
| 321 | PLX | Protalix BioTherapeutics, Inc. | 180.08M | 2.05% | 658,298 | 52.74M |
| 322 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 172.93M | 0.41% | 168,012 | - |
| 323 | ACHV | Achieve Life Sciences, Inc. | 172.50M | 1.25% | 246,126 | - |
| 324 | TLSA | Tiziana Life Sciences Ltd | 163.36M | 1.59% | 134,574 | - |
| 325 | KPTI | Karyopharm Therapeutics Inc. | 162.54M | - | 324,708 | 146.07M |
| 326 | RNAC | Cartesian Therapeutics, Inc. | 161.97M | -2.71% | 117,556 | 2.80M |
| 327 | NKTX | Nkarta, Inc. | 161.83M | 0.89% | 231,564 | - |
| 328 | UNCY | Unicycive Therapeutics, Inc. | 161.77M | -4.04% | 504,705 | - |
| 329 | AGEN | Agenus Inc. | 161.66M | 3.69% | 1,097,419 | 114.20M |
| 330 | WHWK | Whitehawk Therapeutics, Inc. | 160.00M | -1.17% | 149,308 | 7.15M |
| 331 | SPRO | Spero Therapeutics, Inc. | 157.47M | 1.88% | 350,262 | 66.80M |
| 332 | HRTX | Heron Therapeutics, Inc. | 155.37M | 4.40% | 1,020,314 | 154.90M |
| 333 | TNYA | Tenaya Therapeutics, Inc. | 154.05M | 6.34% | 3,302,856 | - |
| 334 | IMUX | Immunic, Inc. | 153.95M | -0.84% | 1,040,482 | - |
| 335 | DTIL | Precision BioSciences, Inc. | 153.79M | -4.79% | 355,077 | 34.26M |
| 336 | ARTV | Artiva Biotherapeutics, Inc. | 153.24M | -7.05% | 130,980 | 251.00K |
| 337 | CNTB | Connect Biopharma Holdings Limited | 150.35M | -5.67% | 366,246 | 64.00K |
| 338 | GALT | Galectin Therapeutics Inc. | 147.45M | 2.28% | 410,991 | - |
| 339 | ACOG | Alpha Cognition Inc. | 146.76M | -3.16% | 73,019 | 10.22M |
| 340 | BDTX | Black Diamond Therapeutics, Inc. | 144.94M | 3.27% | 823,204 | 70.00M |
| 341 | KLRS | Kalaris Therapeutics, Inc. | 144.91M | -2.17% | 91,868 | - |
| 342 | HUMA | Humacyte, Inc. | 143.91M | 6.81% | 3,712,973 | 2.04M |
| 343 | ORMP | Oramed Pharmaceuticals Inc. | 141.36M | -0.71% | 65,458 | 2.00M |
| 344 | MOLN | Molecular Partners AG | 140.32M | 9.30% | 1,440 | 856.30K |
| 345 | FATE | Fate Therapeutics, Inc. | 136.61M | 2.17% | 686,695 | 6.65M |
| 346 | NTHI | NeOnc Technologies Holdings, Inc. | 133.31M | -3.78% | 60,530 | 39.99K |
| 347 | BMEA | Biomea Fusion, Inc. | 126.16M | -8.16% | 3,846,403 | - |
| 348 | IPHA | Innate Pharma S.A. | 119.73M | 7.41% | 18,703 | 10.57M |
| 349 | ANTX | AN2 Therapeutics, Inc. | 119.68M | 0.91% | 115,217 | - |
| 350 | EQ | Equillium, Inc. | 116.97M | -3.65% | 305,340 | 4.39M |
| 351 | GNLX | Genelux Corporation | 116.48M | -0.94% | 155,648 | 8.00K |
| 352 | HURA | TuHURA Biosciences, Inc. | 115.40M | 23.05% | 1,167,897 | - |
| 353 | CBUS | Cibus, Inc. | 113.12M | -6.60% | 1,172,009 | 3.64M |
| 354 | PEPG | PepGen Inc. | 112.31M | -2.69% | 711,749 | - |
| 355 | CRDF | Cardiff Oncology, Inc. | 105.97M | -0.64% | 586,470 | 593.00K |
| 356 | ONCY | Oncolytics Biotech Inc. | 105.03M | 0.49% | 679,541 | - |
| 357 | SGMO | Sangamo Therapeutics, Inc. | 104.60M | -1.41% | 4,917,130 | 39.55M |
| 358 | TTRX | Turn Therapeutics Inc. | 102.83M | 2.74% | 16,355 | - |
| 359 | VRCA | Verrica Pharmaceuticals Inc. | 102.73M | 2.75% | 60,252 | 35.58M |
| 360 | KZIA | Kazia Therapeutics Limited | 102.73M | -6.55% | 278,949 | 1.27M |
| 361 | PMN | ProMIS Neurosciences, Inc. | 98.65M | 1.10% | 16,001 | - |
| 362 | SEER | Seer, Inc. | 95.63M | 0.30% | 75,499 | 16.58M |
| 363 | LONA | LeonaBio, Inc. | 95.63M | -12.84% | 78,536 | - |
| 364 | ALDX | Aldeyra Therapeutics, Inc. | 94.49M | 3.29% | 1,042,521 | - |
| 365 | COYA | Coya Therapeutics, Inc. | 94.30M | 0.75% | 116,522 | 7.95M |
| 366 | PYXS | Pyxis Oncology, Inc. | 93.93M | 2.40% | 138,501 | 13.86M |
| 367 | VANI | Vivani Medical, Inc. | 91.84M | 2.36% | 56,302 | - |
| 368 | ANIX | Anixa Biosciences, Inc. | 89.85M | -0.37% | 103,768 | - |
| 369 | INO | Inovio Pharmaceuticals, Inc. | 89.34M | 4.29% | 2,546,258 | 65.34K |
| 370 | SPRB | Spruce Biosciences, Inc. | 87.81M | 2.98% | 133,639 | 697.00K |
| 371 | EXOZ | eXoZymes, Inc. | 87.42M | 3.00% | 2,064 | -700.00 |
| 372 | CSBR | Champions Oncology, Inc. | 85.75M | 0.57% | 1,871 | 57.95M |
| 373 | AARD | Aardvark Therapeutics, Inc. | 85.74M | -2.72% | 101,565 | - |
| 374 | MCRB | Seres Therapeutics, Inc. | 84.74M | -0.11% | 33,321 | 789.00K |
| 375 | OKYO | OKYO Pharma Limited | 83.97M | - | 95,060 | - |
| 376 | PLRX | Pliant Therapeutics, Inc. | 83.58M | 3.05% | 206,892 | - |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 83.45M | 2.35% | 727,201 | 1.63M |
| 378 | FLNA | Filana Therapeutics, Inc. | 82.12M | 1.80% | 203,081 | - |
| 379 | PYPD | PolyPid Ltd. | 81.29M | 3.40% | 55,343 | - |
| 380 | QTTB | Q32 Bio Inc. | 79.58M | -7.80% | 187,314 | 53.74M |
| 381 | GOSS | Gossamer Bio, Inc. | 79.56M | 2.82% | 5,715,641 | 48.47M |
| 382 | NRXS | NeurAxis, Inc. | 78.65M | -4.22% | 125,845 | 3.57M |
| 383 | ATYR | aTyr Pharma, Inc. | 77.99M | 0.04% | 549,660 | 190.00K |
| 384 | ESLA | Estrella Immunopharma, Inc. | 77.65M | 5.81% | 501,725 | - |
| 385 | PTHS | Pelthos Therapeutics Inc. | 77.35M | 1.36% | 10,266 | 16.80M |
| 386 | GANX | Gain Therapeutics, Inc. | 76.88M | -1.62% | 543,494 | - |
| 387 | CGTX | Cognition Therapeutics, Inc. | 76.58M | 4.84% | 861,383 | - |
| 388 | IBIO | iBio, Inc. | 76.00M | 4.27% | 661,950 | 300.00K |
| 389 | ATHE | Alterity Therapeutics Limited | 75.44M | 3.70% | 13,050 | 4.43M |
| 390 | MAIA | MAIA Biotechnology, Inc. | 74.93M | 2.92% | 567,945 | - |
| 391 | NRXP | NRx Pharmaceuticals, Inc. | 74.33M | 0.90% | 602,992 | 1.23M |
| 392 | BYSI | BeyondSpring Inc. | 74.02M | 4.65% | 12,905 | 1.88M |
| 393 | FBIO | Fortress Biotech, Inc. | 73.42M | -2.98% | 529,164 | 63.26M |
| 394 | IBO | Impact BioMedical Inc. | 73.31M | 1.57% | 198,294 | 32.00K |
| 395 | XBIT | XBiotech Inc. | 72.26M | 3.49% | 20,799 | - |
| 396 | GUTS | Fractyl Health, Inc. | 72.06M | 0.84% | 1,065,877 | 3.00K |
| 397 | MNOV | MediciNova, Inc. | 71.37M | 2.11% | 18,154 | 409.66K |
| 398 | ACET | Adicet Bio, Inc. | 70.14M | 1.48% | 207,896 | - |
| 399 | CING | Cingulate Inc. | 68.49M | -0.84% | 400,609 | - |
| 400 | IFRX | InflaRx N.V. | 68.06M | -2.67% | 257,576 | 34.44K |
| 401 | PMVP | PMV Pharmaceuticals, Inc. | 67.20M | -2.33% | 253,695 | - |
| 402 | COEP | Coeptis Therapeutics Holdings, Inc. | 67.15M | 3.15% | 59,347 | 1.36M |
| 403 | ANVS | Annovis Bio, Inc. | 64.93M | 0.88% | 246,474 | - |
| 404 | DWTX | Dogwood Therapeutics, Inc. | 64.80M | -3.96% | 72,201 | - |
| 405 | TCRX | TScan Therapeutics, Inc. | 60.60M | -0.47% | 788,134 | 10.33M |
| 406 | OKUR | OnKure Therapeutics, Inc. | 59.82M | 1.98% | 92,877 | - |
| 407 | ICCC | ImmuCell Corporation | 59.08M | -1.06% | 13,381 | 27.64M |
| 408 | TIL | Instil Bio, Inc. | 58.32M | 1.78% | 27,124 | - |
| 409 | ACRV | Acrivon Therapeutics, Inc. | 57.73M | 1.36% | 426,800 | - |
| 410 | INKT | MiNK Therapeutics, Inc. | 56.88M | -1.25% | 28,228 | - |
| 411 | HYFT | MindWalk Holdings Corp. | 55.57M | 1.72% | 232,065 | 20.70M |
| 412 | GRCE | Grace Therapeutics, Inc. | 55.40M | 7.51% | 731,293 | - |
| 413 | KZR | Kezar Life Sciences, Inc. | 54.40M | -0.14% | 95,450 | - |
| 414 | PDSB | PDS Biotechnology Corporation | 53.88M | 5.15% | 1,262,859 | - |
| 415 | ENTX | Entera Bio Ltd. | 53.15M | -2.56% | 44,240 | 42.00K |
| 416 | OSTX | OS Therapies Incorporated | 52.97M | 2.44% | 549,573 | - |
| 417 | EDSA | Edesa Biotech, Inc. | 52.60M | -2.15% | 149,518 | - |
| 418 | MGX | Metagenomi Therapeutics, Inc. | 51.79M | 1.22% | 157,538 | 25.21M |
| 419 | RADX | Radiopharm Theranostics Limited | 51.63M | 1.15% | 29,967 | 10.86M |
| 420 | IMA | ImageneBio, Inc. | 51.45M | -3.16% | 15,968 | 800.00K |
| 421 | MREO | Mereo BioPharma Group plc | 51.08M | -2.08% | 1,011,052 | 500.00K |
| 422 | XLO | Xilio Therapeutics, Inc. | 49.82M | 1.35% | 49,406 | 43.77M |
| 423 | ALGS | Aligos Therapeutics, Inc. | 49.13M | 0.51% | 45,490 | 2.19M |
| 424 | NTRB | Nutriband Inc. | 48.38M | -0.50% | 4,980 | 2.28M |
| 425 | HOWL | Werewolf Therapeutics, Inc. | 48.36M | -0.49% | 354,010 | 1.14M |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 46.07M | 1.52% | 32,819 | - |
| 427 | IMMP | Immutep Limited | 46.00M | -2.81% | 717,069 | 5.28M |
| 428 | ACTU | Actuate Therapeutics, Inc. | 45.29M | -9.91% | 69,584 | - |
| 429 | LSTA | Lisata Therapeutics, Inc. | 45.16M | - | 14,761 | 170.00K |
| 430 | RLYB | Rallybio Corporation | 43.90M | 3.11% | 101,835 | 858.00K |
| 431 | RNTX | Rein Therapeutics Inc. | 43.74M | -1.27% | 238,373 | - |
| 432 | RNXT | RenovoRx, Inc. | 42.29M | 4.29% | 118,303 | 1.12M |
| 433 | ATOS | Atossa Therapeutics, Inc. | 41.85M | -0.41% | 61,099 | - |
| 434 | LITS | Lite Strategy, Inc. | 41.82M | 1.77% | 137,082 | - |
| 435 | SNSE | Sensei Biotherapeutics, Inc. | 41.62M | 2.85% | 27,558 | - |
| 436 | ATRA | Atara Biotherapeutics, Inc. | 41.46M | 7.64% | 109,735 | 120.77M |
| 437 | NXTC | NextCure, Inc. | 41.02M | 3.50% | 42,349 | - |
| 438 | CELU | Celularity Inc. | 40.95M | 2.16% | 13,337 | 40.58M |
| 439 | VERU | Veru Inc. | 40.93M | 2.82% | 99,324 | 16.89M |
| 440 | CRVO | CervoMed Inc. | 37.03M | 4.17% | 45,844 | 4.01M |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 36.79M | 0.85% | 113,174 | 90.00K |
| 442 | HYPD | Hyperion DeFi, Inc. | 35.88M | 2.61% | 159,015 | 813.46K |
| 443 | CVM | CEL-SCI Corporation | 35.20M | 2.84% | 42,009 | - |
| 444 | ABVC | ABVC BioPharma, Inc. | 35.09M | -2.07% | 91,623 | 797.92K |
| 445 | PTN | Palatin Technologies, Inc. | 34.38M | -0.74% | 8,652 | 8.96M |
| 446 | INMB | INmune Bio Inc. | 34.16M | 1.18% | 307,267 | 50.00K |
| 447 | DYAI | Dyadic International, Inc. | 33.86M | 5.66% | 6,225 | 3.09M |
| 448 | PLUR | Pluri Inc. | 33.72M | -1.19% | 2,683 | 1.34M |
| 449 | EVAX | Evaxion A/S | 33.53M | 5.79% | 14,110 | 7.53M |
| 450 | LIXT | Lixte Biotechnology Holdings, Inc. | 33.23M | 0.35% | 28,030 | - |
| 451 | APLM | Apollomics, Inc. | 33.09M | 5.19% | 7,782 | 6.93M |
| 452 | LGVN | Longeveron Inc. | 32.50M | -4.31% | 1,049,666 | 1.20M |
| 453 | BCTX | BriaCell Therapeutics Corp. | 31.52M | - | 85,702 | - |
| 454 | KYNB | Kyntra Bio, Inc. | 29.14M | 4.05% | 5,909 | 6.44M |
| 455 | PASG | Passage Bio, Inc. | 28.23M | 7.12% | 47,662 | - |
| 456 | TVRD | Tvardi Therapeutics, Inc. | 27.96M | 4.56% | 63,025 | - |
| 457 | DARE | Daré Bioscience, Inc. | 27.15M | 5.37% | 66,229 | 1.03M |
| 458 | IGC | IGC Pharma, Inc. | 26.90M | 3.77% | 709,589 | 1.11M |
| 459 | SNTI | Senti Biosciences, Inc. | 26.88M | 0.37% | 94,501 | 22.00K |
| 460 | XCUR | Exicure, Inc. | 25.81M | 5.47% | 7,136 | 500.00K |
| 461 | BOLD | Boundless Bio, Inc. | 25.77M | 0.88% | 46,490 | - |
| 462 | OTLK | Outlook Therapeutics, Inc. | 25.75M | 15.54% | 15,489,446 | 205.70K |
| 463 | NRSN | NeuroSense Therapeutics Ltd. | 25.45M | -5.26% | 81,715 | - |
| 464 | NEUP | Neuphoria Therapeutics Inc. | 24.85M | 0.22% | 37,630 | 14.99M |
| 465 | SER | Serina Therapeutics, Inc. | 24.69M | -3.61% | 173,464 | 130.00K |
| 466 | MRKR | Marker Therapeutics, Inc. | 24.68M | 6.47% | 106,203 | 3.55M |
| 467 | LEXX | Lexaria Bioscience Corp. | 24.39M | -1.01% | 115,832 | 522.00K |
| 468 | SKYE | Skye Bioscience, Inc. | 24.05M | 2.05% | 149,887 | - |
| 469 | CUE | Cue Biopharma, Inc. | 23.76M | 29.28% | 34,367,242 | 27.47M |
| 470 | NNVC | NanoViricides, Inc. | 23.54M | 0.93% | 240,726 | - |
| 471 | BRNS | Barinthus Biotherapeutics plc | 23.45M | 6.10% | 14,440 | 14.97M |
| 472 | TVGN | Tevogen Bio Holdings Inc. | 23.30M | 12.35% | 29,854 | - |
| 473 | TPST | Tempest Therapeutics, Inc. | 22.95M | 2.56% | 112,705 | - |
| 474 | AEON | AEON Biopharma, Inc. | 22.83M | -3.78% | 76,836 | - |
| 475 | QNTM | Quantum BioPharma Ltd. | 22.45M | -4.90% | 228,165 | - |
| 476 | CRIS | Curis, Inc. | 22.03M | 0.22% | 1,228,903 | 9.44M |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 21.66M | 2.03% | 291,417 | 789.00K |
| 478 | PSTV | Plus Therapeutics, Inc. | 21.27M | 6.16% | 982,652 | 5.21M |
| 479 | LTRN | Lantern Pharma Inc. | 20.96M | 6.25% | 254,016 | - |
| 480 | VYNE | VYNE Therapeutics Inc. | 20.81M | 5.33% | 82,484 | 570.00K |
| 481 | COCP | Cocrystal Pharma, Inc. | 20.13M | -0.68% | 395,698 | - |
| 482 | KTTA | Pasithea Therapeutics Corp. | 19.23M | -3.38% | 73,893 | - |
| 483 | JSPR | Jasper Therapeutics, Inc. | 19.14M | 2.38% | 506,727 | - |
| 484 | PLRZ | Polyrizon Ltd. | 18.70M | 4.02% | 17,092 | - |
| 485 | ALLR | Allarity Therapeutics, Inc. | 18.59M | 1.29% | 47,446 | 320.00K |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 18.53M | 4.96% | 244,395 | 3.94M |
| 487 | ICU | SeaStar Medical Holding Corporation | 16.57M | -0.48% | 59,163 | 1.23M |
| 488 | GNTA | Genenta Science S.p.A. | 15.88M | -2.78% | 42,464 | - |
| 489 | LPCN | Lipocine Inc. | 15.69M | 7.50% | 1,649,737 | 1.98M |
| 490 | HIND | Vyome Holdings, Inc. | 15.58M | 5.21% | 9,805 | 319.71K |
| 491 | OSRH | OSR Holdings, Inc. | 15.25M | -6.31% | 707,038 | 2.91M |
| 492 | PHIO | Phio Pharmaceuticals Corp. | 14.70M | 2.02% | 59,596 | - |
| 493 | INAB | IN8bio, Inc. | 14.38M | 2.10% | 35,643 | - |
| 494 | INTS | Intensity Therapeutics, Inc. | 13.80M | 3.43% | 27,268 | - |
| 495 | TOVX | Theriva Biologics, Inc. | 13.40M | 17.03% | 7,147,976 | - |
| 496 | JUNS | Jupiter Neurosciences, Inc. | 13.24M | 4.29% | 48,597 | 21.80K |
| 497 | BCDA | BioCardia, Inc. | 13.24M | 1.68% | 163,005 | 3.00K |
| 498 | MBRX | Moleculin Biotech, Inc. | 13.10M | 1.87% | 80,646 | - |
| 499 | KAPA | Kairos Pharma, Ltd. | 12.79M | 0.71% | 22,067 | - |
| 500 | GTBP | GT Biopharma, Inc. | 12.62M | -3.22% | 403,605 | - |